內地網絡售藥監管細則11月實施 購買處方藥須實名制
內地《北京日報》報道,網絡售藥監管辦法實施細則11月實施,網上出售處方藥要對買藥人士的信息,實行實名制管理,另外在網站首頁、醫藥健康行業板塊首頁及平台商家店舖主頁,不得展示處方藥包裝及標簽等信息,網售處方藥記錄保存期限不少於五年。
北京市藥監局11月1日起正式執行《北京市藥品網絡銷售監督管理辦法實施細則》,是全國首個省、直轄市藥品監管部門出台的藥品網絡銷售監督管理規範性文件。
按照細則的要求,藥品網絡銷售以線上線下一體化監管,即線上銷售的藥品必須經過藥監部門上市許可;線上銷售藥品的主體,必須是取得相應資質的藥品生產或經營企業。按照線上線下職能一致、業務歸口管理一致的原則,建立統一部署、督導及考核的監管機制,推動藥品網絡銷售監管規範化、制度化及法治化。
細則明確規定,從事藥品網絡銷售的企業,只需通過北京市藥監局企業服務平台進行報告,即可開展藥品網絡銷售業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.